Despite the strong correlation between the high-SPP1 group and improved tumor immunogenicity as well as inflamed antitumor immunity, it is still necessary to further explore the potential molecular mechanism how SPP1 reacts with immune-related cells. This evidence concerns the gene SPP1 and neoplasm.